| AEFI |
Adverse event following immunization |
| ALRI |
Acute lower respiratory infection |
| cMYP |
Comprehensive multi-year plan |
| DQS |
Data quality self-assessment |
| EPI |
Expanded programme on immunization |
| ERL |
Essential Regulatory Laboratory |
| GACVS |
Global Advisory Committee on Vaccine Safety |
| HA |
Haemagglutinin |
| HIV |
Human immunodeficiency virus |
| HSA |
Health surveillance assistant (Malawi) |
| ICC |
Inter-agency coordinating committee |
| IEC |
Information, education and communication |
| ILI |
Influenza-like illness |
| KABP |
Knowledge, attitudes, beliefs and practices |
| LMIS |
Logistics management information system |
| M&E |
Monitoring and evaluation |
| NIC |
National Influenza Centre |
| NITAG |
National Immunization Technical Advisory Group |
| PAHO |
Pan American Health Organization |
| PIE |
Post-introduction evaluation |
| RMNCAH |
Programme manager for reproductive, maternal, newborn, child and adolescent health |
| RMSD |
Regional Medical Supply Division (Sri Lanka) |
| SAGE |
WHO’s Strategic Advisory Group of Experts on Immunization |
| SARI |
Severe Acute Respiratory Infection |
| TT2+ |
Reported number of second, third, fourth and fifth doses of TT administered to pregnant women during a calendar year |
| UNICEF |
United Nations Children’s Fund |
| VVM |
Vaccine vial monitor |
| WHO |
World Health Organization |
